Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GERM CELLS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02668770
What this trial is testing

Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced CancersMelanoma
M.D. Anderson Cancer Center 28
Large-scale testing (Phase 3)Study completedNCT00037869
What this trial is testing

High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsMetastases, Neoplasm
M.D. Anderson Cancer Center 15
Early research (Phase 1)Ended earlyNCT04751383
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma

Who this might be right for
High Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT04071561
What this trial is testing

Prevention of Conversion in Posterior Retroperitoneal Adrenalectomy by Measuring Preoperative Anatomical Conditions

Who this might be right for
Adrenal TumorAdrenal MassPheochromocytoma+3 more
University of Basel 14
Not applicableStudy completedNCT00785369
What this trial is testing

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Who this might be right for
Skin CancerMelanomaLentigo Maligna
Lucid, Inc. 441
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableActive Not RecruitingNCT01696994
What this trial is testing

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

Who this might be right for
Ovarian CarcinomaOvarian Germ Cell Tumor
National Cancer Institute (NCI) 78,216
Testing effectiveness (Phase 2)Ended earlyNCT00389090
What this trial is testing

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Keryx / AOI Pharmaceuticals, Inc. 32
Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Ended earlyNCT01814046
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Testing effectiveness (Phase 2)Study completedNCT00014573
What this trial is testing

Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT01482741
What this trial is testing

Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging

Who this might be right for
Breast CancerColon CancerLung Cancer+2 more
Memorial Sloan Kettering Cancer Center 30
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Study completedNCT01792505
What this trial is testing

Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma

Who this might be right for
Malignant Glioma
Cedars-Sinai Medical Center 71
Testing effectiveness (Phase 2)Looking for participantsNCT06818331
What this trial is testing

Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

Who this might be right for
Glioma
The Third Affiliated hospital of Zhejiang Chinese Medical University 20
Very early researchActive Not RecruitingNCT04947501
What this trial is testing

N9 Chemotherapy in Children With Neuroblastoma

Who this might be right for
NeuroblastomaPediatric Cancer
Memorial Sloan Kettering Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT00436436
What this trial is testing

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00001439
What this trial is testing

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Who this might be right for
Melanoma
National Cancer Institute (NCI) 255
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Next Page